V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20028422 | 20085708 | 1.84 | 88 | Palliative (P) | 2019-07-28 | 2019-09-01 | Capecitabine + Cisplatin + RT | 2 | N | CAPECITABINE + CISPLATIN + RT | 101353684 |
| 20028439 | 20085709 | 1.63 | 105.1 | null | 2018-08-30 | 2018-09-05 | Enzalutamide | 02 | null | CAPECITABINE + TEMOZOLOMIDE | 100256758 |
| 20028444 | 20085710 | 1.7 | 79.6 | Palliative (P) | 2018-10-20 | 2018-10-20 | Capecitabine + Cisplatin + RT | 02 | N | ECF | 100858678 |
| 20028487 | 20085711 | 1.72 | 47 | null | 2019-11-10 | 2019-11-18 | Enzalutamide | N | null | CARBOPLATIN + PACLITAXEL + RT | 100246461 |
| 20028671 | 20085713 | 1.55 | null | Palliative (P) | 2020-03-19 | 2020-03-20 | Enzalutamide | null | N | LUTETIUM-177 | 101790963 |
| 20028678 | 20085714 | null | 92.6 | Palliative (P) | 2018-04-15 | 2018-04-17 | Enzalutamide | 02 | N | CARBOPLATIN | 100889345 |
| 20028705 | 20085715 | null | 88 | Palliative (P) | 2018-04-02 | 2018-04-02 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101210345 |
| 20028724 | 20085716 | 1.81 | 78 | Palliative (P) | 2018-04-12 | 2018-04-18 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101086502 |
| 20028804 | 20085718 | 0 | 0 | Palliative (P) | 2018-04-08 | 2018-04-09 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100580913 |
| 20028847 | 20085719 | 1.72 | 62.9 | Neo-adjuvant (N) | null | 2018-05-18 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101234516 |
| 20028852 | 20085720 | 1.79 | 70.8 | Palliative (P) | 2017-07-23 | 2017-07-26 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101100364 |
| 20028868 | 20085721 | 1.63 | null | Palliative (P) | 2018-12-29 | 2019-01-06 | Enzalutamide | 02 | Y | ECF | 100283771 |
| 20028872 | 20085722 | 1.67 | 62.8 | Neo-adjuvant (N) | null | 2020-08-20 | Enzalutamide | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100200258 |
| 20028882 | 20085723 | 0 | 79.7 | Neo-adjuvant (N) | 2017-03-03 | 2017-03-31 | Enzalutamide | 02 | N | CARBOPLATIN | 101530667 |
| 20028910 | 20085724 | 1.72 | 61.5 | Palliative (P) | 2018-08-31 | 2018-09-01 | Enzalutamide | 02 | N | LUTETIUM-177 | 101256543 |
| 20028956 | 20085725 | null | null | null | 2015-10-21 | 2015-12-03 | Enzalutamide | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100529746 |
| 20028962 | 20085726 | 1.66 | 104.9 | Palliative (P) | 2015-10-16 | 2015-10-16 | Enzalutamide | 02 | null | ECF | 101428581 |
| 20029014 | 20085727 | 1.87 | 101.5 | Adjuvant (A) | 2018-01-02 | 2018-01-15 | Enzalutamide | 02 | N | CISPLATIN | 101161316 |
| 20029025 | 20085728 | 1.6 | 48.5 | null | null | 2019-02-10 | NEO-AEGIS TRIAL | null | N | AZACITIDINE | 100241537 |
| 20029026 | 20085729 | 1.58 | 61.15 | 03 | 2018-07-01 | 2018-07-04 | Panitumumab | 01 | N | TIPIRACIL + TRIFLURIDINE | 100167130 |
| 20029065 | 20085730 | 1.72 | 56 | null | 2019-04-04 | 2019-04-13 | CVP R | N | N | CAPECITABINE + OXALIPLATIN + RT | 101153331 |
| 20029073 | 20085731 | 1.9 | 63.7 | Palliative (P) | 2017-02-12 | 2017-02-13 | null | 02 | N | EOF | 100246059 |
| 20029139 | 20085732 | 1.52 | 63.3 | null | 2017-04-05 | 2017-04-05 | IRINOTECAN + MDG + PANITUMUMAB | 01 | null | FLUOROURACIL + RT | 101453873 |
| 20029141 | 20085733 | 1.78 | 97 | null | null | 2020-06-01 | Carboplatin + Pemetrexed | Y | null | EOF | 101038201 |
| 20029182 | 20085734 | 1.73 | 94 | Palliative (P) | 2019-02-13 | 2019-02-13 | EEF or EOF | 02 | N | GEMCITABINE + PACLITAXEL | 100734312 |
| 20029235 | 20085735 | 1.5 | 77.2 | null | 2020-12-22 | 2020-12-27 | CHOP R - 21 days | 01 | N | PALBOCICLIB | 101687945 |
| 20029256 | 20085736 | 1.78 | 65 | null | 2017-10-15 | 2017-10-15 | Gemcitabine + Paclitaxel | 02 | N | NOT MATCHED | 100396814 |
| 20029260 | 20085737 | 1.58 | 53.6 | Palliative (P) | 2017-11-05 | 2017-11-07 | ABC-08 Trial | N | N | PAZOPANIB | 100332183 |
| 20029289 | 20085738 | 1.62 | 52.8 | Neo-adjuvant (N) | 2019-08-24 | 2019-09-07 | EOF | N | N | FOXTROT TRIAL | 100936315 |
| 20029304 | 20085739 | 1.7 | 61.1 | Palliative (P) | 2017-06-01 | 2017-06-13 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100728754 |
| 20029305 | 20085740 | 1.82 | 48 | null | 2019-02-18 | 2019-02-25 | CARBOPLATIN + VINORELBINE | Y | Y | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101309770 |
| 20029322 | 20085741 | 1.66 | 117.4 | 03 | 2017-01-01 | 2017-01-04 | ABVD | N | N | ACALABRUTINIB | 100048230 |
| 20029348 | 20085742 | 1.54 | 54.9 | Palliative (P) | 2020-01-15 | 2020-01-18 | GO2 TRIAL | 01 | Y | CISPLATIN + TEYSUNO | 101614561 |
| 20029374 | 20085743 | 1.83 | 85 | 03 | 2017-10-14 | 2017-10-21 | ACTICCA-1 Trial | 02 | N | BENDAMUSTINE + THALIDOMIDE | 100567196 |
| 20029403 | 20085745 | 1.68 | 89 | 03 | 2017-02-25 | 2017-03-04 | CISPLATIN + FLUOROURACIL + MITOMYCIN | 02 | N | IRINOTECAN | 100223309 |
| 20029441 | 20085746 | 1.73 | 107.45 | 03 | 2019-07-31 | 2019-08-07 | ARISTOTLE TRIAL | null | N | CAPITAL TRIAL | 101808794 |
| 20029480 | 20085747 | 1.88 | 58.6 | 03 | 2018-03-22 | 2018-03-22 | PEMBROLIZUMAB | 02 | N | CAPECITABINE + STREPTOZOCIN | 100358470 |
| 20029483 | 20085748 | 0 | 0 | 03 | 2019-04-26 | 2019-05-02 | EEF or EOF | 02 | N | MPV | 100559513 |
| 20029579 | 20085749 | 1.56 | 64.5 | 03 | 2018-01-15 | 2018-01-22 | EOF | 02 | N | FOXTROT TRIAL | 100831972 |
| 20029616 | 20085750 | 1.82 | 84.35 | Adjuvant (A) | 2019-09-20 | 2019-10-12 | SCOPE 2 TRIAL | 01 | N | CARBOPLATIN + VINORELBINE | 101317396 |
| 20029632 | 20085751 | 1.71 | 115 | Palliative (P) | 2018-07-27 | 2018-08-03 | Trabectedin | 02 | N | DOCETAXEL | 100397061 |
| 20029720 | 20085753 | 1.6 | 78.8 | 03 | 2018-02-16 | 2018-02-24 | PLATO Trials | N | N | PLATO TRIAL | 101511925 |
| 20029737 | 20085754 | 1.61 | 69 | Palliative (P) | 2016-08-17 | 2016-08-29 | CARBOPLATIN + FLUOROURACIL | 02 | N | HYDROXYCARBAMIDE | 101547489 |
| 20029746 | 20085755 | 1.82 | 53 | Palliative (P) | 2018-07-06 | 2018-07-06 | TCH (21 day Trastuzumab) Loading | 02 | N | FLUOROURACIL + RT | 100787192 |
| 20029793 | 20085756 | 1.6 | 56.6 | Curative (C) | 2020-10-01 | 2020-10-02 | Binimetinib + Cetuximab + Encorafenib | 02 | N | CHOP R | 100755939 |
| 20029794 | 20085757 | null | null | null | 2016-09-02 | 2016-09-02 | IBRUTINIB | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100507930 |
| 20029802 | 20085758 | 1.68 | 67.5 | 03 | 2018-11-15 | 2018-11-16 | Panitumumab | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN + PANITUMUMAB | 101807115 |
| 20029849 | 20085759 | 1.81 | 73.9 | Adjuvant (A) | 2017-10-31 | 2017-11-05 | CARBOPLATIN + FLUOROURACIL | 02 | N | CARBOPLATIN + FLUOROURACIL | 101003201 |
| 20029913 | 20085760 | 1.79 | 53.25 | Palliative (P) | 2019-06-25 | 2019-06-26 | FCarboSt | 02 | N | EVEROLIMUS | 101471288 |
| 20029921 | 20085761 | 1.71 | 65.95 | null | 2019-10-02 | 2019-12-26 | OXALIPLATIN | 02 | N | PALBOCICLIB | 100976610 |